497 related articles for article (PubMed ID: 26755877)
1. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
Park YS; Lee CH; Kim JW; Shin S; Park CM
World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
[TBL] [Abstract][Full Text] [Related]
2. Liver tumor characterization--comments and illustrations regarding guidelines.
Dietrich CF
Ultraschall Med; 2012 Jul; 33 Suppl 1():S22-30. PubMed ID: 22723025
[TBL] [Abstract][Full Text] [Related]
3. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
4. [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound].
Schuessler G; Ignee A; Hirche T; Dietrich CF
Z Gastroenterol; 2003 Dec; 41(12):1167-76. PubMed ID: 14661127
[TBL] [Abstract][Full Text] [Related]
5. [Liver tumor as incidental ultrasound finding].
Görtz RS; Strobel D
MMW Fortschr Med; 2010 Jan; 152(3):41-3. PubMed ID: 20333967
[No Abstract] [Full Text] [Related]
6. Characterisation of focal liver lesions with contrast enhanced ultrasonography.
Dietrich CF
Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.
Kim YY; Park MS; Aljoqiman KS; Choi JY; Kim MJ
Clin Mol Hepatol; 2019 Sep; 25(3):223-233. PubMed ID: 30661336
[TBL] [Abstract][Full Text] [Related]
10. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
[TBL] [Abstract][Full Text] [Related]
11. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
[TBL] [Abstract][Full Text] [Related]
12. Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI.
Song KD; Jeong WK
Clin Mol Hepatol; 2015 Jun; 21(2):187-91. PubMed ID: 26157758
[No Abstract] [Full Text] [Related]
13. Benign focal liver lesions masquerading as primary liver cancers on MRI.
Subramanian M; Low HM; Kim MJ; Tan CH
Diagn Interv Radiol; 2020 May; 26(3):168-175. PubMed ID: 32229432
[TBL] [Abstract][Full Text] [Related]
14. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
15. Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.
Sagrini E; Iavarone M; Stefanini F; Tovoli F; Vavassori S; Maggioni M; Renzulli M; Salvatore V; Stefanescu H; Colombo M; Bolondi L; Piscaglia F
United European Gastroenterol J; 2019 Feb; 7(1):69-77. PubMed ID: 30788118
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
17. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.
Sheybani A; Gaba RC; Lokken RP; Berggruen SM; Mar WA
Curr Gastroenterol Rep; 2017 Oct; 19(11):58. PubMed ID: 29044439
[TBL] [Abstract][Full Text] [Related]
18. Hepatic hemangiomas: the various imaging avatars and its mimickers.
Mathew RP; Sam M; Raubenheimer M; Patel V; Low G
Radiol Med; 2020 Sep; 125(9):801-815. PubMed ID: 32249391
[TBL] [Abstract][Full Text] [Related]
19. Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay.
Cheung HM; Law C; Shoichet M; Karanicolas PJ; Coburn N; Milot L
Can Assoc Radiol J; 2016 Aug; 67(3):242-9. PubMed ID: 27318891
[No Abstract] [Full Text] [Related]
20. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
Kim JH; Joo I; Lee JM
Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
